Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

94.66
Delayed Data
As of Oct 16
 -0.46 / -0.48%
Today’s Change
78.42
Today|||52-Week Range
100.51
+14.27%
Year-to-Date
No recent news for Biomarin Pharmaceutical Inc.

Today’s Trading

Previous close95.12
Today’s open95.13
Day’s range94.56 - 96.05
Volume747,848
Average volume (3 months)1,317,714
Market cap$16.7B
Dividend yield--
Data as of 3:59pm ET, 10/16/2017

Growth & Valuation

Earnings growth (last year)-256.07%
Earnings growth (this year)+81.09%
Earnings growth (next 5 years)+127.00%
Revenue growth (last year)+27.18%
P/E ratioNM
Price/Sales12.40
Price/Book5.94

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV+0.23+0.61%
PRGOPerrigo Company PLC-0.74-0.84%
JAZZJazz Pharmaceuticals...-0.88-0.62%
ALNYAlnylam Pharmaceutic...-1.11-0.91%
Data as of 4:02pm ET, 10/16/2017

Financials

Next reporting dateOctober 26, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$1.1B
Annual profit (last year)-$630.2M
Net profit margin-56.74%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Dan Spiegelman
Corporate headquarters
San Rafael, California

Forecasts